Revolutionizing Alzheimer's disease and clinical trials through biomarkers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

Published:2015-10-02 Issue:4 Volume:1 Page:412-419
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

Mattsson Niklas¹,Carrillo Maria C.²,Dean Robert A.³,Devous Michael D.⁴,Nikolcheva Tania⁵,Pesini Pedro⁶,Salter Hugh⁷⁸,Potter William Z.⁹,Sperling Reisa S.¹⁰,Bateman Randall J.¹¹,Bain Lisa J.¹²,Liu Enchi¹³

Affiliation:

1. Clinical Memory Research UnitLund UniversitySweden

2. Alzheimer's AssociationChicagoILUSA

3. Eli Lilly & Co, Inc.IndianapolisINUSA

4. Avid RadiopharmaceuticalsPhiladelphiaPAUSA

5. F. Hoffmann‐La RocheBaselSwitzerland

6. Araclon GrifolsZaragozaSpain

7. AztraZenecaStockholmSweden

8. Department of Clinical NeuroscienceKarolinska InstitutetSweden

9. Foundation for the NIHBethesdaMDUSA

10. Brigham and Women's HospitalBostonMAUSA

11. Washington University School of MedicineSt. LouisMOUSA

12. ElversonPAUSA

13. Janssen Research and Development, LLC.San DiegoCAUSA

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.dadm.2015.09.001

Reference84 articles.

1. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

2. Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease

3. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

4. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

5. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer’s disease? An umbrella review;IBRO Neuroscience Reports;2024-06

2. Novel Biomarkers for Alzheimer’s Disease: Plasma Neurofilament Light and Cerebrospinal Fluid;International Journal of Alzheimer's Disease;2024-05-15

3. Delayed primacy recall performance predicts post mortem Alzheimer's disease pathology from unimpaired ante mortem cognitive baseline;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-01

4. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach;Methods in Molecular Biology;2024

5. Digital Marker for Early Screening of Mild Cognitive Impairment Through Hand and Eye Movement Analysis in Virtual Reality Using Machine Learning: First Validation Study;Journal of Medical Internet Research;2023-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3